Clinical Trial Update: A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 adaptive, randomized, double-blind, placebo-controlled trial (REVIVE) evaluating a therapy for Long COVID-19 Syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Cardresearch | Conditions: Long COVID-19 Syndrome, Chronic Fatigue Syndrome | Phase 3 | Status: COMPLETED